(2R,3S,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3-ol, 98%, 100mg

6-(Trifluoromethyl)piperidin-2-one, 98%, 250mg

(R)-N-[1-(5,6,7,8-Tetrahydronaphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-propylamine, 98%, 250mg

N-[(1S,2S)-2-({2-[(2-methylpropane-2-sulfinyl)amino]-3,4-dioxocyclobut-1-en-1-yl}amino)-1,2-diphenylethyl]-3,5-bis(trifluoromethyl)benzamide, 96.28%, 100mg

Methyl 1-aminocyclohexanecarboxylate hydrochloride, 95.0%, 1g

Potassium carbonate, min. 98%, 1 kg, plastic packaging.

2-Mercaptopyridine>98.0%(HPLC)(T)25g

3-Fluoro-4-methoxy-2-methylaniline, 95+%, 1g

7-BROMO-4-HYDROXY-2H-CHROMEN-2-ONE, 95.0%, 5g

4-(tert-Butyl)oxazol-2-amine, 95.0%, 1g

6-Chloroflavone>98.0%(GC)1g

3-(Cyclobutylmethyl)-7-fluoro-1H-indole, 1g

Ethyl but-3-enoate (contains <30ppm MEHQ as inhibitor), 88.0%, 1g